Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
Int J Surg Case Rep ; 44: 226-229, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29547849

RESUMEN

INTRODUCTION: Secondary pancreatic tumors are uncommon and account for 2-5% of pancreatic cancer. Tumors characterized most commonly with pancreatic involvement are lymphoma, renal cell and lung carcinomas. PRESENTATION OF CASE: A 76-year-old female patient with obstructive jaundice as the primary symptom and inguinal lymphadenopathy is presented. Imaging revealed a bulky solitary solid pancreatic head mass along with paraaortic and mesenteric lymphadenopathy. The absence of a previous history of malignancy and the presence of a dominant pancreatic mass along with distal lymphadenopathy confined differential diagnosis to advanced secondary pancreatic lymphoma, which is the most common secondary pancreatic tumor, and locally advanced/metastatic pancreatic adenocarcinoma. Pathologic confirmation with excisional biopsy of an enlarged inguinal lymph node and EUS-FNB of the pancreatic head mass confirmed the diagnosis of secondary Non-Hodgkin pancreatic lymphoma allowing initiation of induction chemotherapy. DISCUSSION: Secondary pancreatic lymphoma can be seen up to 30% of patients with advanced lymphoma; although the head of the pancreas is the most common location, obstructive jaundice is not the predominant symptom as obstruction of the common bile duct is usually absent. In the setting of a solitary nodular type pancreatic mass, key imaging findings highly suggestive of secondary pancreatic lymphoma and not of adenocarcinoma are the absence of vascular invasion, bile and pancreatic duct obstruction, and the presence of lymphadenopathy below the level of the left renal vein. CONCLUSION: When a secondary pancreatic tumor is highly suspected pathologic confirmation is always needed before initiation of induction or palliative chemotherapy.

2.
Surg Oncol ; 24(4): 322-8, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26690821

RESUMEN

Dynamic CT has a reported sensitivity of as high as 97% in the detection of pancreatic cancer. Consequently, a substantial number of pancreatic tumors can still escape detection. The isoattenuating pancreatic adenocarcinoma is defined as a mass not directly visible on dynamic CT as its attenuation is indistinguishable from the attenuation of the pancreatic parenchyma. 88% and 100% of the isoattenuating adenocarcinomas <20 mm and >20 mm respectively are recognized only by the presence of secondary imaging findings highly suggestive of malignancy. Dynamic MRI can unmask 80% of the isoattenuating pancreatic adenocarcinomas. If MRI fails to unmask the mass, EUS-biopsy is not mandatory to be performed as biopsy proof is not required for solid pancreatic masses suspicious for malignancy before proceeding to surgery. The isoattenuating adenocarcinomas should not be regarded as early cancers as less than one-third of them are stage T1 tumors. After curative intent surgery, isoattenuating pancreatic adenocarcinoma patients have a significantly longer median survival than usual pancreatic adenocarcinoma patients associated with the higher rate of well differentiated tumors among isoattenuating tumors. The more favorable postsurgical survival of the isoattenuating pancreatic adenocarcinoma patients makes it even more imperative to correctly diagnose their cases at a resectable stage.


Asunto(s)
Adenocarcinoma/diagnóstico , Adenocarcinoma/cirugía , Neoplasias Pancreáticas/diagnóstico , Neoplasias Pancreáticas/cirugía , Humanos , Imagen por Resonancia Magnética , Pronóstico , Tomografía Computarizada por Rayos X
3.
Clin Obes ; 3(5): 158-61, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25586631

RESUMEN

Band erosion is a rare complication of laparoscopic adjustable gastric banding (LAGB) with a reported prevalence varying from 0.3% to 14%. Intraluminal colonic erosion of the connecting tube is very rare, as only isolated cases have been described. Consequently, simultaneous gastric band erosion and connecting tube colonic erosion is an extremely rare event. Herein, we present a case of a woman with morbid obesity, who submitted to LABG 4 years ago. The patient presented with symptoms and signs of right lower quadrant peritonitis. Computed tomography (CT) demonstrated migration of the band into the gastric lumen, inflammation around the intra-abdominal course of the connecting tube and an inflammatory mass surrounding the tube at the right lower quadrant. Laparotomy revealed the eroded band, the eroded transverse colon from the connecting tube, a gastrocolic fistula along the course of the tube and a right lower quadrant phlegmon. The connecting tube was mobilized from the surrounding adherent tissues, the gastric band removed, the stomach and colon walls closed, and the gastrocolic fistula excised. To our knowledge this is the second case of concurrent band erosion and connecting tube colonic erosion along with gastrocolic fistula formation in a patient with morbid obesity treated with LAGB.

4.
Minerva Chir ; 62(4): 241-8, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17641584

RESUMEN

AIM: The aim of this study was to investigate whether iloprost injected intraperitoneally immediately after colon resection can improve anastomotic healing on the fifth and eighth postoperative days. METHODS: Forty Wistar rats were randomised into 2 equal groups. After the resection of a 1 cm segment of transverse colon, an end to end sutured anastomosis was generated. From the day of the operation, group 1 (control) received intraperitoneal 3 cc saline solution once daily until sacrifice, while group 2 (iloprost) received iloprost in a dose of 2 mg/kg body weight intraperitoneally once daily until sacrifice. Each group was further randomly divided into 2 equal subgroups and animals were sacrificed on the fifth (subgroup A), and eighth (subgroup B) postoperative days. After sacrifice, anastomoses were examined macroscopically and were measured for bursting pressures and tissue hydroxyproline levels while anastomotic healing process was evaluated histopathologically. RESULTS: None of the rats exhibited any clinical evidence of leakage and there were no instances of peri-anastomotic abscess or peritonitis. Bursting pressure on the fifth postoperative day was significantly higher in the iloprost group than in the control group (P<0.001), while on the eighth postoperative day, bursting pressure was higher in the iloprost group but not significantly different (P=0.165). On both the fifth and eighth postoperative days rats in the iloprost group developed significantly more marked neo-angiogenesis and, in parallel with this, there was a trend showing a higher inflammatory cell infiltration. CONCLUSION: The intraperitoneal administration of iloprost promoted neo-angiogenesis and enhanced colonic healing on the fifth postoperative day.


Asunto(s)
Anastomosis Quirúrgica , Inductores de la Angiogénesis/administración & dosificación , Colon/cirugía , Epoprostenol/análogos & derivados , Iloprost/administración & dosificación , Cicatrización de Heridas/efectos de los fármacos , Animales , Colon/efectos de los fármacos , Modelos Animales de Enfermedad , Inyecciones Intraperitoneales , Distribución Aleatoria , Ratas , Ratas Wistar
5.
Dis Colon Rectum ; 50(6): 899-907, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17353975

RESUMEN

PURPOSE: This experimental study was designed to investigate whether iloprost can reverse impaired colonic healing caused by immediate postoperative intraperitoneal administration of 5-fluorouracil plus leucovorin. METHODS: Eighty Wistar rats were randomized into four groups. After resection of a 1-cm segment of transverse colon, an end-to-end sutured anastomosis was generated. Rats received saline solution (Group 1), 5-fluorouracil plus leucovorin (Group 2), iloprost (Group 3), and 5-fluorouracil plus leucovorin plus iloprost (Group 4) intraperitoneally from the day of operation and once daily until killing. Each group was further randomized into two subgroups. Subjects were killed on the fifth (Subgroup a) and eighth (Subgroup b) postoperative days. After killing, anastomoses were examined macroscopically and graded histologically. Rats were measured for anastomotic bursting pressures and tissue hydroxyproline levels. RESULTS: The leakage rate of the anastomoses was significantly higher in the 5-fluorouracil plus leucovorin group compared with the other groups (P = 0.049). Bursting pressure was significantly lower in 2a subgroup (5-fluorouracil plus leucovorin, postoperative Day 5) than in 4a (5-fluorouracil plus leucovorin plus iloprost, postoperative Day 5; P < 0.001). Adhesion formation was significantly higher in all b subgroups compared with the Control b subgroup. Neoangiogenesis was significantly higher in iloprost and iloprost plus 5-fluorouracil plus leucovorin subgroups compared with the 5-fluorouracil plus leucovorin subgroups. Hydroxyproline levels, collagen deposition, fibroblasts, and white cell count were significantly higher in the iloprost plus 5-fluorouracil plus leucovorin b subgroup (postoperative Day 8) compared with the 5-fluorouracil plus leucovorin b subgroup (postoperative Day 8). CONCLUSIONS: The immediate postoperative, intraperitoneal administration of iloprost counteracts and reverses the negative effects of 5-fluorouracil plus leucovorin chemotherapy and protects colonic healing in rats.


Asunto(s)
Colon/cirugía , Iloprost/farmacología , Complicaciones Posoperatorias/tratamiento farmacológico , Vasodilatadores/farmacología , Cicatrización de Heridas/efectos de los fármacos , Anastomosis Quirúrgica/efectos adversos , Animales , Antimetabolitos Antineoplásicos/administración & dosificación , Antimetabolitos Antineoplásicos/efectos adversos , Colágeno/efectos de los fármacos , Colágeno/metabolismo , Colon/metabolismo , Femenino , Fibroblastos/efectos de los fármacos , Fibroblastos/metabolismo , Fluorouracilo/administración & dosificación , Fluorouracilo/efectos adversos , Hidroxiprolina/metabolismo , Inyecciones Intraperitoneales , Leucovorina/administración & dosificación , Leucovorina/efectos adversos , Manometría , Modelos Animales , Neovascularización Fisiológica/efectos de los fármacos , Complicaciones Posoperatorias/inducido químicamente , Distribución Aleatoria , Ratas , Ratas Wistar , Adherencias Tisulares/inducido químicamente , Adherencias Tisulares/prevención & control , Complejo Vitamínico B/administración & dosificación , Complejo Vitamínico B/efectos adversos
6.
World J Surg ; 31(1): 186-91, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17171478

RESUMEN

BACKGROUND: It has been well established that the immediate postoperative intraperitoneal administration of chemotherapeutic agents such as 5-fluorouracil (5-FU) after curative colon resection for colon cancer destroys disseminated cancer cells and inhibits micrometastases but also inhibits anastomotic healing. On the other hand, the application of fibrin glue constitutes a physical barrier around the anastomosis and may prevent anastomotic leakage. The purpose of this experimental study was to determine the effect of 5-FU plus interferon (IFN)-alpha-2a on the integrity of colonic anastomoses covered with fibrin glue when injected intraperitoneally immediately after colon resection. MATERIALS AND METHODS: Sixty rats were randomized to one of four groups. After resection of a 1-cm segment of the transverse colon, an end-to-end sutured anastomosis was performed. Rats of the control and the fibrin glue groups were injected with 6 ml of 0.9% sodium chloride (NaCl) solution intraperitoneally. Rats in the 5-FU + IFN and the 5-FU + IFN + fibrin glue groups received 5-FU plus IFN intraperitoneally. The colonic anastomoses of the rats in the fibrin glue and in the 5-FU + IFN + fibrin glue groups were covered with fibrin glue. All rats were sacrificed on the 8th postoperative day, and the anastomoses were examined macroscopically. The bursting pressure measurements were recorded, and the anastomoses were graded histologically. RESULTS: Only the 5-FU + IFN group had anastomoses rupture, and the rupture rate (33%) in this group was significantly greater than in the other groups, where there were no ruptures (P = 0.015). The adhesion formations score was, on average, significantly higher in rats of the 5-FU + IFN group compared with the control group (P = 0.006) and the 5-FU + IFN + fibrin glue group (P = 0.010). Bursting pressures were significantly lower in the control group when compared to the fibrin glue and 5-FU + IFN + fibrin glue group (P < 0.001). Rats in the 5-FU + IFN + fibrin glue group developed significantly more marked neoangiogenesis than rats in the other groups. Inflammatory cell infiltration, collagen deposition, and fibroblast activity did not differ significantly among the four groups (P = 0.856, P = 0.192 and P = 0.243, respectively). CONCLUSION: The immediate postoperative intraperitoneal administration of 5-FU plus IFN impairs colonic healing. However, when the colonic anastomoses were covered with fibrin glue, the injection of 5-FU plus IFN had no adverse effects on the integrity of the anastomoses.


Asunto(s)
Anastomosis Quirúrgica , Antimetabolitos Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Colon/cirugía , Adhesivo de Tejido de Fibrina/uso terapéutico , Fluorouracilo/farmacología , Interferones/uso terapéutico , Adhesivos Tisulares/uso terapéutico , Cicatrización de Heridas/efectos de los fármacos , Animales , Antimetabolitos Antineoplásicos/uso terapéutico , Fluorouracilo/uso terapéutico , Inyecciones Intraperitoneales , Masculino , Ratas , Ratas Wistar
7.
Int Angiol ; 25(1): 84-9, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16520730

RESUMEN

In its more severe form heparin induced thrombocytopenia (HIT) is a rare immune mediated complication of heparin administration that potentially has catastrophic results, and significant mortality. In view of the severity of this condition it is important for the clinician to maintain a high index of suspicion and get alerted to the HIT syndrome by the precocity of platelet count decrease in any patient group, and especially in those previously exposed to heparin. We report on a 72-year-old woman who developed HIT syndrome that was complicated by recurrent arterial thromboses after receiving postoperative antithrombotic prophylaxis with tinzaparin, a low molecular weight heparin. The patient was successfully treated with iloprost (Ilomedin, iloprost tromethamine, Schering) a stable prostacyclin analogue, at the acute phase of the syndrome, followed by long-term treatment with clopidogrel (Plavix, clopidogrel bisulfate, Sanofi) an inhibitor of adenosine diphosphate (ADP) receptor. Although direct thrombin inhibitors have been proven to be effective for the treatment of HIT thrombosis, they do not completely eliminate the morbidity and mortality of this disorder. Our case report suggests that antithrombotic treatment by targeting of the activated platelets with a potent platelet inhibitor during the acute phase of type II HIT syndrome followed by long-term administration of oral anticoagulation may be an additional, safe and effective therapeutic alternative that merits to be systematically studied.


Asunto(s)
Arteriopatías Oclusivas/tratamiento farmacológico , Fibrinolíticos/efectos adversos , Heparina de Bajo-Peso-Molecular/efectos adversos , Iloprost/uso terapéutico , Trombocitopenia/inducido químicamente , Trombosis/tratamiento farmacológico , Trombosis/etiología , Ticlopidina/análogos & derivados , Anciano , Arteriopatías Oclusivas/diagnóstico , Clopidogrel , Quimioterapia Combinada , Femenino , Humanos , Arteria Ilíaca/diagnóstico por imagen , Arteria Ilíaca/patología , Pierna/irrigación sanguínea , Inhibidores de Agregación Plaquetaria/uso terapéutico , Arteria Poplítea/diagnóstico por imagen , Arteria Poplítea/patología , Radiografía , Recurrencia , Síndrome , Trombocitopenia/complicaciones , Ticlopidina/uso terapéutico , Tinzaparina
8.
World J Surg Oncol ; 4: 8, 2006 Feb 08.
Artículo en Inglés | MEDLINE | ID: mdl-16466577

RESUMEN

BACKGROUND: The Muir-Torre syndrome is a rare autosomal dominant condition and is currently considered a subtype of the more common hereditary nonpolyposis colorectal cancer syndrome, in which multiple primary malignancies occur together with sebaceous gland tumors. CASE PRESENTATION: We describe a case of a 62-year-old woman with three primary colorectal tumors, genital tumor, and sebaceous adenomas and present her family history of three generations. Our case represents the first case reported from Greece in the international literature. CONCLUSION: Recognition of the syndrome in patients with sebaceous gland tumors should facilitate early detection of subsequent malignancies if the patient is entered into appropriate screening programs.

9.
Eur Surg Res ; 37(5): 317-20, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16374015

RESUMEN

The aim of this prospective study is to describe the combined technique and results of stapled haemorrhoidopexy and lateral internal sphincterotomy for patients suffering from prolapsing 3rd-degree haemorrhoids and chronic fissure-in-ano. During the period from 1999 to 2004, 26 patients underwent combined surgical treatment for anal fissure and prolapsing symptomatic haemorrhoids. Preoperative and postoperative clinical evaluation and the patient's degree of satisfaction were recorded. Early complications included faecal urgency (3 patients) and pain (2 patients). Complete continence was restored within 10 weeks in all patients except 1 who had persisting incontinence to flatus. All fissures healed completely within 4 weeks. No haemorrhoidal or fissure recurrence has been observed during follow-up. The combination of stapled haemorrhoidopexy and lateral internal sphincterotomy is a safe and effective procedure for the treatment of prolapsing 3rd-degree haemorrhoids and chronic anal fissures.


Asunto(s)
Canal Anal/cirugía , Fisura Anal/cirugía , Hemorroides/cirugía , Grapado Quirúrgico , Adulto , Terapia Combinada , Femenino , Fisura Anal/complicaciones , Estudios de Seguimiento , Hemorroides/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias , Estudios Prospectivos
10.
Tech Coloproctol ; 8(3): 185-7, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15654528

RESUMEN

Stapling procedure is a new technique for the surgical management of prolapsing haemorrhoids. Some articles have reported severe adverse effects of this operation. We describe a case of an excessive staple-line stenosis followed stapled haemorrhoidopexy. Proctoscopic dilatation resulted in complications of retropneumoperitoneum, pneumomediastinum, subcutaneous emphysema and perianal abscess. Drainage of the abscess was performed, allowing quick recovery. After discharge from the hospital, the patient continued to perform periodic dilatation. Simple proctoscopic dilatation was conducted in an outpatient setting.


Asunto(s)
Enfermedades del Ano/terapia , Dilatación/efectos adversos , Hemorroides/cirugía , Enfisema Mediastínico/etiología , Grapado Quirúrgico/efectos adversos , Absceso/etiología , Absceso/cirugía , Enfermedades del Ano/etiología , Constricción Patológica/etiología , Constricción Patológica/terapia , Drenaje , Humanos , Masculino , Persona de Mediana Edad , Neumoperitoneo/etiología , Enfisema Subcutáneo/etiología
11.
Tech Coloproctol ; 8 Suppl 1: s119-22, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15655593

RESUMEN

BACKGROUND: The aim of our study is to present the preliminary results of an ongoing radio-frequency (RF) ablation study in patients with hepatic metastases from colorectal cancer. PATIENTS AND METHODS: From November 2003, two patients affected with metachronous liver metastases from colorectal cancer were treated with RF ablation. The mean age of the patients was 66 years (58 and 74 years). Tumours were unifocal right-lobe lesions in one patient and bifocal in the second patient. Under general anaesthesia, a Radionics 200-W RF generator was used to ablate lesions with H2O-cooled electrodes via laparotomy. Patients' follow-up ranged from two to five months including evaluation of salient clinical, radiological and laboratory parameters. RESULTS: The patients experienced moderate-to-severe pain in the right abdomen lasting for 2-3 days and mild fever for 3-6 days after treatment. During the follow-up period no local recurrence was observed. CONCLUSIONS: RF ablation emerges to be a promising method for the treatment of hepatic metastases from colorectal cancer.


Asunto(s)
Adenocarcinoma/secundario , Ablación por Catéter/métodos , Neoplasias Colorrectales/patología , Neoplasias Hepáticas/secundario , Neoplasias Hepáticas/cirugía , Adenocarcinoma/cirugía , Anciano , Biopsia con Aguja , Neoplasias Colorrectales/cirugía , Estudios de Seguimiento , Humanos , Inmunohistoquímica , Neoplasias Hepáticas/patología , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Procedimientos Quirúrgicos Mínimamente Invasivos/métodos , Estadificación de Neoplasias , Medición de Riesgo , Tomografía Computarizada por Rayos X , Resultado del Tratamiento
12.
Tech Coloproctol ; 8 Suppl 1: s132-4, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15655597

RESUMEN

BACKGROUND: To determine the incidence of local recurrence, after curative resection for rectal cancer, with the application of total mesorectal excision (TME). PATIENTS AND METHODS: During the last ten years, 120 patients underwent curative resection for rectal cancer. As a rule, except for the cases that underwent high anterior resection, TME was applied. In terms of local relapse, routine TME, preoperative radiotherapy, tumour's stage, differentiation grade and number of positive nodes were taken into account. RESULTS: Eight patients (6.7%) presented with local relapse. At 5 years, 91.9% of patients were free of local recurrence and the actuarial disease-free survival was 81%. A significant association between routine TME, tumour's stage, differentiation grade, lymph node invasion and local recurrence was observed. Conversely, preoperative radiotherapy appeared to play no protective role. CONCLUSIONS: The curative resection of rectal cancer, with the application of TME, has led to a very low incidence of local relapse during the last few years.


Asunto(s)
Recurrencia Local de Neoplasia/epidemiología , Recurrencia Local de Neoplasia/patología , Neoplasias del Recto/patología , Neoplasias del Recto/cirugía , Adulto , Distribución por Edad , Anciano , Estudios de Cohortes , Intervalos de Confianza , Supervivencia sin Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Probabilidad , Neoplasias del Recto/mortalidad , Estudios Retrospectivos , Medición de Riesgo , Distribución por Sexo , Análisis de Supervivencia
13.
Tech Coloproctol ; 8 Suppl 1: s53-5, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15655643

RESUMEN

BACKGROUND: The purpose of this study is to present the incidence of anastomotic leakage after colon resection and intraperitoneal anastomosis for colorectal cancer. PATIENTS AND METHODS: In the last ten years, 205 patients underwent colonic resection with intraperitoneal anastomosis for colon cancer. The surgical management of colorectal cancer consisted of 66 right hemicolectomies, 3 transverse colectomies, 17 left hemicolectomies, 98 sigmoid colectomies and 21 high anterior resections of the rectum. Diagnosis of leakage was made by clinical features, blood vessel examinations and abdominal CT-scans. RESULTS: Anastomotic leakage occurred in 5 out of 205 patients (2.4%). One of these patients underwent emergency surgery and the other 4 elective surgery; 3 by manual, 2 by mechanical suture. Three patients with anastomotic leakage were reoperated on days 4, 5 and 7, and 2 patients were treated conservatively. Two of the patients (20%) with anastomotic leakage died due to sepsis. CONCLUSIONS: Even though the rate of anastomotic leakage in patients with intraperitoneal anastomosis after colon resection for colorectal cancer is low, it remains a significant complication and a major cause of postoperative morbidity and mortality.


Asunto(s)
Anastomosis Quirúrgica/efectos adversos , Colectomía/efectos adversos , Neoplasias Colorrectales/cirugía , Complicaciones Posoperatorias/epidemiología , Adulto , Distribución por Edad , Anciano , Anciano de 80 o más Años , Anastomosis Quirúrgica/métodos , Estudios de Cohortes , Colectomía/métodos , Neoplasias Colorrectales/mortalidad , Neoplasias Colorrectales/patología , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Medición de Riesgo , Distribución por Sexo , Análisis de Supervivencia
14.
Tech Coloproctol ; 8 Suppl 1: s72-5, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15655650

RESUMEN

BACKGROUND: The aim of this study is to underscore the incidence of synchronous polyps in patients with colorectal cancer and to emphasise the importance of their perioperative detection and management. PATIENTS AND METHODS: Three hundred and seven patients underwent a potentially curative resection for colorectal cancer during the last ten years. A total of 129 synchronous polyps were detected in 72 of the patients (23.5%). Complete preoperative colonoscopy was performed in 62 of the patients. Forty-three polyps (33.4%) in 37 patients were removed preoperatively, while 69 polyps (53.4%) in 25 patients were included in the surgical specimen. In 10 patients the colon was evaluated postoperatively and 17 polyps (13.1%) were removed via endoscopy. RESULTS: A total of 81 polyps were detected in different surgical segments than the index cancer. Furthermore, 15 polyps were detected in the right colon of 55 patients with left colon cancer. CONCLUSIONS: Synchronous polyps in patients with colorectal cancer are a frequent event. Thus, all patients should undergo a perioperative colonoscopy and endoscopic polypectomy, if feasible. The planned surgical procedure may alter as a consequence of the colonoscopic findings in some of the patients.


Asunto(s)
Colectomía/métodos , Pólipos del Colon/epidemiología , Pólipos del Colon/cirugía , Neoplasias Colorrectales/epidemiología , Neoplasias Colorrectales/cirugía , Adulto , Distribución por Edad , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Pólipos del Colon/diagnóstico , Colonoscopía/métodos , Neoplasias Colorrectales/diagnóstico , Comorbilidad , Femenino , Estudios de Seguimiento , Grecia/epidemiología , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Cuidados Preoperatorios/métodos , Estudios Retrospectivos , Medición de Riesgo , Distribución por Sexo , Análisis de Supervivencia , Resultado del Tratamiento
15.
Tech Coloproctol ; 8 Suppl 1: s89-92, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15655655

RESUMEN

BACKGROUND: To examine the role of TNM staging system as a predictive factor for postoperative morbidity and mortality, after colorectal cancer resections. PATIENTS AND METHODS: During the last ten years, 368 patients with colorectal cancer were referred to our institution. All patients, who underwent primary treatment elsewhere or defunctioning colostomy only, or who did not undergo surgical therapy were excluded from the analysis. The early postoperative outcomes registration of the remaining 351 patients (197 men, median age 66.2 years) was retrospectively linked to TNM stage. RESULTS: TNM stage had a poor prognostic value for the early postoperative morbidity rate. In addition, according to the statistical analysis, the proportion of early postoperative mortality proved to be higher in patients with TNM stage III or IV colorectal cancer. CONCLUSIONS: TNM classification could be considered as a reliable predictor of early postoperative mortality, but has no role in the prediction of early postoperative morbidity after colorectal resections.


Asunto(s)
Colectomía/efectos adversos , Neoplasias Colorrectales/mortalidad , Neoplasias Colorrectales/patología , Estadificación de Neoplasias/clasificación , Complicaciones Posoperatorias/mortalidad , Adulto , Anciano , Biopsia con Aguja , Colectomía/métodos , Neoplasias Colorrectales/cirugía , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Morbilidad/tendencias , Valor Predictivo de las Pruebas , Cuidados Preoperatorios/métodos , Pronóstico , Estudios Retrospectivos , Medición de Riesgo , Análisis de Supervivencia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA